跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 43 条关于
“CALGB”
全部
43
临床试验
32
药物
0
机构
0
资讯
11
16年前
KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
去年
Physical Activity Significantly Improves Survival Outcomes in Stage III Colon Cancer Patients
去年
Bevacizumab Benefits in Colorectal Cancer Limited to Two-Year Window, New Analysis Reveals
9个月前
Blood Test Using ctDNA Identifies Colon Cancer Patients Who Benefit from Celecoxib Anti-Inflammatory Therapy
去年
Anti-Inflammatory Diet Reduces Death Risk by 87% in Stage III Colon Cancer Patients
去年
Luminal A DCIS Shows Strong Response to Letrozole in Phase II Trial, Genomic Study Reveals
去年
ctDNA Status Predicts Celecoxib Benefit in Stage III Colon Cancer
去年
Celecoxib Improves Outcomes in Colon Cancer Patients with Residual ctDNA
9个月前
Exelixis and Natera Launch Phase 3 Trial Testing Zanzalintinib in MRD-Positive Colorectal Cancer Patients
去年
Multidisciplinary Approach Drives De-escalation of Breast Cancer Surgery Through Targeted Axillary Management
第 1 页,共 2 页
上一页
下一页